Translation and Validation of the Turkish Version of the ObsQoR-10 Questionnaire (ObsQoR-10T)
NCT ID: NCT04729192
Last Updated: 2021-10-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2021-02-05
2021-10-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
The patients will complete the ObsQoR-10T questionnaire on day 1 following delivery
ObsQoR-10T Questionnaire
The ObsQoR-10T questionnaire consists of 10 items assessing physical comfort and pain, physical independence, and emotional status. Each item is scored from 0 to 10 and the total score is the sum of the score for each item, which is a score from 0 to 110.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ObsQoR-10T Questionnaire
The ObsQoR-10T questionnaire consists of 10 items assessing physical comfort and pain, physical independence, and emotional status. Each item is scored from 0 to 10 and the total score is the sum of the score for each item, which is a score from 0 to 110.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Spontaneous vaginal delivery with or without neuraxial anesthesia for labor analgesia (including repair of vaginal tears and manual removal of the placenta) or elective cesarean delivery
* Women who have singleton births
* Primiparous (first baby) -≥38 weeks gestational age
Exclusion Criteria
* Age \< 18 years
* Women whose infants have died
* Mother or baby requiring ICU after delivery.
* Patient refusal to participate
* Inability to read or understand written Turkish
* Failed neuraxial analgesia: elective cesarean delivery
* General anesthesia
* Intrapartum cesarean
* Assisted/operative (i.e. vacuum, forceps) vaginal delivery
18 Years
48 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Konya Meram State Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Betul Kozanhan
Ass.Prof.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Betul Kozanhan
Konya, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ObsQoR-10T
Identifier Type: -
Identifier Source: org_study_id